Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose atropine to improve binocular balance in adults
ChiCTR2600130157Phase 4Not yet recruiting
- Sponsor
- Hangzhou Xihu Zhijiang Eye Hospital
- Start
- Aug 2026
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of atropine in amblyopia, anisometropia and Binocular Vision Dysfunction (BVD) (3 arms), sponsored by Hangzhou Xihu Zhijiang Eye Hospital. Primary endpoint: Binocular balance. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
atropine
03
Conditions
amblyopiaanisometropiaBinocular Vision Dysfunction (BVD)
Beyond the preview
Go deeper on ChiCTR2600130157.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600130157.